A landmark clinical trial published in the Journal of Perinatology has resolved a long-standing dilemma facing Japan's neonatal clinicians: how to provide the critical early nutrition that extremely ...
DUARTE, Calif., April 30, 2026 /PRNewswire/ -- A landmark clinical trial published in the Journal of Perinatology has resolved a long-standing dilemma facing Japan's neonatal clinicians: how to ...
DUARTE, Calif., Feb. 19, 2026 /PRNewswire/ -- Prolacta Bioscience® today announced that Japan's Ministry of Health, Labour and Welfare (MHLW) has approved PreemieFort® Enteral Solution, a 100% human ...
The MarketWatch News Department was not involved in the creation of this content. Japan's Ministry of Health, Labour and Welfare (MHLW) Approves PreemieFort(R) Enteral Solution as Prescription ...
Clinigen obtained approval for Prolacta's "PreemieFort® Enteral Solution", a human milk-based fortifier, as an approved pharmaceutical product in Japan indicated for the "Nutritional management of ...
The MarketWatch News Department was not involved in the creation of this content. Prolacta Offers the Only Nutritional Products Free From Cow Milk and Added Synthetic Ingredients Like Corn Syrup for ...
November is Prematurity Awareness Month, a time to celebrate the progress that has been made for premature babies nationwide. These are some of the smallest, most fragile patients. And one of the ...
DUARTE, Calif., Oct. 14, 2025 /PRNewswire/ — Prolacta Bioscience®, the world’s leading hospital provider of 100% human milk-based nutritional products for critically ill and premature infants, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results